Cassava Sciences Inc (NASDAQ:SAVA) currently has a daily average trading volume of 3.70M but it saw 20208233 shares traded in last market. With a market cap of 199.24M USD, the company’s current market price of $3.98 came rising about 4.05 while comparing to the previous closing price of $3.83. In past 52 weeks, the stock remained buoying in the range of price level as high as $42.20 and as low as $3.65. In the recent trading on the day, stock has struck highest price mark of $3.71 while lowest mark touched by it was $4.15.
Taking a look at 20-day trading activity of Cassava Sciences Inc (SAVA) gives us an average price of $23.25, while its current price level is -90.57% below from 52-week high level whereas it is 9.04% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $26.00 while that of 200 days or SMA-200 reads an average of $22.65. A closer look into the stock’s movement over the week reveals that its volatility is standing at 23.31% during that period while stretching the period over a month that decreases to 11.53%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 23.61 which implies that the stock is in oversold territory.
H.C. Wainwright upgraded its recommendation for the stock as a “Buy” from “Neutral” on October 08, 2024 while assigning a price target of $116.
Over the week, SAVA’s stock price is moving -84.72% down while it is -84.99% when we observe its performance for the past one month. Year-to-date it is -82.32% down and over the past year, the stock is showing a downside performance of -80.82%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.5 beaten by the consensus estimate of -0.4 for the same. The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of -0.68 while estimate for next year EPS is -1.58.
Currently, Cassava Sciences Inc’s total number of outstanding shares is 42.24M with 12.68% of that held by the insiders while 29.95% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -10.60% and return on equity (ROE) at -10.98%. Stock’s beta reads -0.84. Stock has a price to book (P/B) ratio of 1.15. Its return on asset (ROA) is -8.91% on average.
